Connection

Krzysztof Filipiak to Percutaneous Coronary Intervention

Back to Details
This is a "connection" page, showing publications Krzysztof Filipiak has written about Percutaneous Coronary Intervention.
Krzysztof Filipiak
Connection Strength
1.036
Percutaneous Coronary Intervention
  1. Platelet to red cell distribution width ratio for predicting clopidogrel efficacy in patients undergoing percutaneous coronary interventions: insights from the ONSIDE-TEST study. Pol Arch Intern Med. 2019 02 28; 129(2):117-122.
    View in: PubMed
    Score: 0.231
  2. Can prasugrel decrease the extent of periprocedural myocardial injury during elective percutaneous coronary intervention? Pol Arch Intern Med. 2017 11 30; 127(11):730-740.
    View in: PubMed
    Score: 0.208
  3. Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trial. J Thromb Thrombolysis. 2019 Apr; 47(3):427-435.
    View in: PubMed
    Score: 0.058
  4. Switching between P2Y12 antagonists - From bench to bedside. Vascul Pharmacol. 2019 04; 115:1-12.
    View in: PubMed
    Score: 0.058
  5. Bivalirudin use in acute coronary syndrome patients undergoing percutaneous coronary interventions in Poland: Clinical update from expert group of the Association on Cardiovascular Interventions of the Polish Cardiac Society. Cardiol J. 2019; 26(1):1-7.
    View in: PubMed
    Score: 0.057
  6. Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction. Platelets. 2020; 31(1):26-32.
    View in: PubMed
    Score: 0.057
  7. A serial 3- and 9-year optical coherence tomography assessment of vascular healing response to sirolimus- and paclitaxel-eluting stents. Int J Cardiovasc Imaging. 2019 Jan; 35(1):9-21.
    View in: PubMed
    Score: 0.056
  8. A serial three- and nine-year optical coherence tomography evaluation of neoatherosclerosis progression after sirolimus- and paclitaxel- -eluting stent implantation. Kardiol Pol. 2018; 76(8):1251-1256.
    View in: PubMed
    Score: 0.055
  9. Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry. Catheter Cardiovasc Interv. 2018 01 01; 91(1):115-123.
    View in: PubMed
    Score: 0.052
  10. Peripheral ARtery Atherosclerotic DIsease and SlEep disordered breathing (PARADISE) trial - protocol for an observational cohort study. Kardiol Pol. 2017; 75(12):1332-1338.
    View in: PubMed
    Score: 0.052
  11. In-Scaffold Neovascularization 24 Months After Bioresorbable Vascular Scaffold Implantation in a Patient With ST-Segment Elevation Myocardial Infarction. JACC Cardiovasc Interv. 2017 07 10; 10(13):e123-e125.
    View in: PubMed
    Score: 0.051
  12. Optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective PCI patients: A pilot study: ONSIDE TEST pilot. Cardiol J. 2017; 24(3):284-292.
    View in: PubMed
    Score: 0.050
  13. Percutaneous Closure of Post-Infarction Ventricular Septal Defects-An Over Decade-long Experience. J Interv Cardiol. 2017 Feb; 30(1):63-71.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.